 | Up a level |
Valenzuela, Pedro L; Ruilope, Luis M; Santos-Lozano, Alejandro; Wilhelm, Matthias; Kränkel, Nicolle; Fiuza-Luces, Carmen; Lucia, Alejandro (2023). Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation. European Heart Journal, 44(21), pp. 1874-1889. Oxford University Press 10.1093/eurheartj/ehad170
Messerli, Franz H; Bavishi, Chirag; Brguljan, Jana; Burnier, Michel; Dobner, Stephan; Elijovich, Fernando; Ferdinand, Keith C; Kjeldsen, Sverre; Laffer, Cheryl L; S Ram, C Venkata; Rexhaj, Emrush; Ruilope, Luis M; Shalaeva, Evgeniya V; Siontis, George C M; Staessen, Jan A; Textor, Stephen C; Vongpatanasin, Wanpen; Vogt, Liffert; Volpe, Massimo; Wang, Jiguang; ... (2022). Renal denervation in the antihypertensive arsenal - knowns and known unknowns. Journal of hypertension, 40(10), pp. 1859-1875. Wolters Kluwer Health 10.1097/HJH.0000000000003171
Bakris, George L; Agarwal, Rajiv; Anker, Stefan D; Pitt, Bertram; Ruilope, Luis M; Rossing, Peter; Kolkhof, Peter; Nowack, Christina; Schloemer, Patrick; Joseph, Amer; Filippatos, Gerasimos (2020). Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. The New England journal of medicine, 383(23), pp. 2219-2229. Massachusetts Medical Society 10.1056/NEJMoa2025845
Bakris, George L; Agarwal, Rajiv; Anker, Stefan D; Pitt, Bertram; Ruilope, Luis M; Nowack, Christina; Kolkhof, Peter; Ferreira, Anna C; Schloemer, Patrick; Filippatos, Gerasimos (2019). Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. American journal of nephrology, 50(5), pp. 333-344. Karger 10.1159/000503713
